Literature DB >> 19414145

Genetic testing in gastroenterology: Lynch syndrome.

Shilpa Grover1, Sapna Syngal.   

Abstract

Lynch syndrome/Hereditary non-polyposis colorectal cancer is caused by inherited germline mutations in mismatch repair (MMR) genes, and accounts for 2-5% of colorectal cancers (CRC) . It is characterized by young onset CRC and an increased risk for gynaecologic, urinary tract and gastrointestinal cancers. Family history evaluation is crucial in the early identification of individuals at risk for Lynch syndrome. Individuals whose family history includes multiple relatives with cancer, two or more primary cancers, or component tumours diagnosed at a young age, should undergo genetic evaluation for Lynch syndrome. Guidelines recommend initial evaluation of the tumour with immunohistochemistry or microsatellite instability testing followed by germline testing for mutations in MMR genes in those with abnormal results. Genetic test results can guide screening recommendations for patients and their families. However, results are not always conclusive and in such cases recommendations for cancer screening should be individualized on the basis of personal and family history.

Entities:  

Mesh:

Year:  2009        PMID: 19414145     DOI: 10.1016/j.bpg.2009.02.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  8 in total

1.  Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012.

Authors:  Nils Rahner; Verena Steinke; Brigitte Schlegelberger; Francois Eisinger; Pierre Hutter; Sylviane Olschwang
Journal:  Eur J Hum Genet       Date:  2012-08-15       Impact factor: 4.246

2.  Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2).

Authors:  Nils Rahner; Verena Steinke; Brigitte Schlegelberger; Sylviane Olschwang; François Eisinger; Pierre Hutter
Journal:  Eur J Hum Genet       Date:  2010-01-27       Impact factor: 4.246

Review 3.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version).

Authors:  Hideyuki Ishida; Tatsuro Yamaguchi; Kohji Tanakaya; Kiwamu Akagi; Yasuhiro Inoue; Kensuke Kumamoto; Hideki Shimodaira; Shigeki Sekine; Toshiaki Tanaka; Akiko Chino; Naohiro Tomita; Takeshi Nakajima; Hirotoshi Hasegawa; Takao Hinoi; Akira Hirasawa; Yasuyuki Miyakura; Yoshie Murakami; Kei Muro; Yoichi Ajioka; Yojiro Hashiguchi; Yoshinori Ito; Yutaka Saito; Tetsuya Hamaguchi; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Hiroshi Kawano; Yusuke Kinugasa; Norihiro Kokudo; Keiko Murofushi; Takako Nakajima; Shiro Oka; Yoshiharu Sakai; Akihiko Tsuji; Keisuke Uehara; Hideki Ueno; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Narikazu Boku; Takahiro Fujimori; Michio Itabashi; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Yasuhiro Shimada; Keiichi Takahashi; Shinji Tanaka; Osamu Tsuruta; Toshiharu Yamaguchi; Kenichi Sugihara; Toshiaki Watanabe
Journal:  J Anus Rectum Colon       Date:  2018-05-25

4.  Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico.

Authors:  Wilfredo E De Jesus-Monge; Carmen Gonzalez-Keelan; Ronghua Zhao; Stanley R Hamilton; Miguel Rodriguez-Bigas; Marcia Cruz-Correa
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

5.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.

Authors:  Naohiro Tomita; Hideyuki Ishida; Kohji Tanakaya; Tatsuro Yamaguchi; Kensuke Kumamoto; Toshiaki Tanaka; Takao Hinoi; Yasuyuki Miyakura; Hirotoshi Hasegawa; Tetsuji Takayama; Hideki Ishikawa; Takeshi Nakajima; Akiko Chino; Hideki Shimodaira; Akira Hirasawa; Yoshiko Nakayama; Shigeki Sekine; Kazuo Tamura; Kiwamu Akagi; Yuko Kawasaki; Hirotoshi Kobayashi; Masami Arai; Michio Itabashi; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2021-06-29       Impact factor: 3.402

6.  Risk assessment, genetic testing, and management of Lynch syndrome.

Authors:  Shilpa Grover; Sapna Syngal
Journal:  J Natl Compr Canc Netw       Date:  2010-01       Impact factor: 11.908

7.  CoDP: predicting the impact of unclassified genetic variants in MSH6 by the combination of different properties of the protein.

Authors:  Hiroko Terui; Kiwamu Akagi; Hiroshi Kawame; Kei Yura
Journal:  J Biomed Sci       Date:  2013-04-28       Impact factor: 8.410

8.  NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.

Authors:  Pi-Yueh Chang; Jinn-Shiun Chen; Nai-Chung Chang; Shih-Cheng Chang; Mei-Chia Wang; Shu-Hui Tsai; Ying-Hao Wen; Wen-Sy Tsai; Err-Cheng Chan; Jang-Jih Lu
Journal:  Oncotarget       Date:  2016-06-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.